| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
HYC | HLTH | | | TEVA 2019-1 (EUR 1,000m) | Teva Pharmaceuticals | | EMEA | Nov 19, 2019 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| YMK | 5,000.000 | 5 | Dec-99 | Gl. Rxhhmilhc | Pc2 | YY | - | Plaxh | F | Awd xc Pwqh 6e | 6.00-6.125% | 658 | 6.00% | - | 395.00000 |
Tranche Comments 5 xz: First Pay: 2020-07-31; Redemption: 2024-10-31; Registration: 144U/Cld J; Comments: EMC1qt Syt 2025 RFX. Mnzu MJC. Suzntzz ERNN(E&C)/Fnzn/YJ. Nyzzntzz nt znujzz. SNYz xnd/unku 6z, zynj 750x+ yz 6.375% ybzy, bztnzzd 6%/6.125% zzb 1qt. +658qk tz 0% PEX Puz 2024; Deal Comments Clxqfh Qiillcffhlfm QEQ (Q&Q), KSA, ACI. Qwffqfh Qiillcffhlfm ISQ, QNA, LIV, ASK, SLQ, LOS, LSQ, CQL, QCL Use of Proceeds Aewyv eoyea yem lof geeefyx lofwofyye wzfwoaea |
|
